The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells
Abstract
Objective: Regulatory T cells play an important role in the prevention of autoimmunity and have been shown to be effective in the treatment of experimental colitis, a T cell–mediated and organ‐specific disease. We previously demonstrated that intrinsic CD25+ regulatory T cells modulate the severity of collagen‐induced arthritis (CIA), which, in contrast to colitis, is a systemic antibody‐mediated disease and an accepted model of rheumatoid arthritis. We undertook this study to determine whether regulatory T cells have the potential to be used therapeutically in arthritis. Methods: We transferred CD4+,CD25+ T cells into mice exhibiting arthritis symptoms, both immunocompetent mice and mice subjected to lethal irradiation and rescued with syngeneic bone marrow transplantation. Results: A single transfer of regulatory T cells markedly slowed disease progression, which could not be attributed to losses of systemic type II collagen–specific T and B cell responses, since these remained unchanged after adoptive transfer. However, regulatory T cells could be found in the inflamed synovium soon after transfer, indicating that regulation may occur locally in the joint. Conclusion: Our data indicate that CD25+ regulatory T cells can be used for the treatment of systemic, antibody‐mediated autoimmune diseases, such as CIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Powrie, F., Leach, M. W., Mauze, S., Caddie, L. B., & Coffman, R. L. (1993) · International Immunology · doi:10.1093/intimm/5.11.1461 · Cited by 1,078
Cited by
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Niedbala, W., Wei, X., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737810 · Cited by 588
Augello, A., Tasso, R., Negrini, S. M., Cancedda, R., & Pennesi, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22511 · Cited by 587
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Roncarolo, M.-G., & Battaglia, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2138 · Cited by 515
González, M. A., Gonzalez‐Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24405 · Cited by 489
The Th17/Treg imbalance in patients with acute coronary syndrome
Cheng, X., Yu, X., Ding, Y.-J., Fu, Q.-Q., Xie, J.-J., Tang, T.-T., Yao, R., Chen, Y., & Liao, Y.-H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.009 · Cited by 489
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 420
Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R., & Edinger, M. (2006) · Blood · doi:10.1182/blood-2006-06-027409 · Cited by 407
Bouffi, C., Bony, C., Courties, G., Jorgensen, C., & Noël, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014247 · Cited by 383
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00727-y · Cited by 367
Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage
Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.-K., Fischer, R., Schwarz, I., Rahn, H.-P., Plehm, R., Wellner, M., Elitok, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.832782 · Cited by 339
Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes
Mor, A., Luboshits, G., Planer, D., Keren, G., & George, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl222 · Cited by 336
CTLA-4: From mechanism to autoimmune therapy
Hosseini, A., Gharibi, T., Marofi, F., Babaloo, Z., & Baradaran, B. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106221 · Cited by 297
Etiology and Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2017) · Kelley and Firestein's Textbook of Rheumatology · doi:10.1016/b978-0-323-31696-5.00069-3 · Cited by 278
PD-1/PD-L and autoimmunity: A growing relationship
Zamani, M. R., Aslani, S., Salmaninejad, A., Javan, M. R., & Rezaei, N. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.09.009 · Cited by 266
Arntz, O. J., Pieters, B. C. H., Oliveira, M. C., Broeren, M. G. A., Bennink, M. B., de Vries, M., van Lent, P. L. E. M., Koenders, M. I., van den Berg, W. B., van der Kraan, P. M., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500222 · Cited by 255
Zaiss, M. M., Sarter, K., Hess, A., Engelke, K., Böhm, C., Nimmerjahn, F., Voll, R., Schett, G., & David, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27535 · Cited by 122
T Regulatory Cells in Bone Remodelling
Bozec, A., & Zaiss, M. M. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0356-1 · Cited by 110
The Treg/Th17 Imbalance in Patients with Idiopathic Dilated Cardiomyopathy
Li, J., Wang, L., Wang, S., Zhu, H., Ye, P., Xie, A., Shen, B., Liu, C., Guo, C., Fu, Q., et al. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02374.x · Cited by 50
Okamura, T., Yamamoto, K., & Fujio, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00340 · Cited by 41
“Other approaches to adoptive Treg cell therapy using either Foxp3-dependent or Foxp3-independent Tregs have been demonstrated in various autoimmune disease mouse models, including SLE (71, 84), type 1 diabetes (85), EAE (86), inflammatory bowel disease (13, 87), and collagen-induced arthritis (CIA) (88).”
BackgroundInfluential
Metadata
- Authors
- Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de vries, R. R. P., & Toes, R. E. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-06-28
- Volume
- 52
- Issue
- 7
- Pages
- 2212-2221
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2120313632
- Cited by
- 385
- References
- 37
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.